🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the manufacturers of acetaminophen, claiming the firms hid potential risks that the medication presented to children's cognitive development.

The court filing arrives four weeks after Former President Trump promoted an unverified association between consuming acetaminophen - alternatively called acetaminophen - during pregnancy and autism spectrum disorder in young ones.

Paxton is filing suit against J&J, which previously sold the drug, the only pain reliever approved for pregnant women, and the current manufacturer, which presently makes it.

In a statement, he said they "betrayed America by making money from discomfort and marketing drugs without regard for the dangers."

The company asserts there is insufficient reliable data linking acetaminophen to autism spectrum disorder.

"These manufacturers deceived for years, deliberately risking countless individuals to line their pockets," Paxton, a Republican, declared.

The manufacturer stated officially that it was "seriously troubled by the spread of false claims on the reliability of acetaminophen and the possible consequences that could have on the well-being of American women and children."

On its online platform, the company also said it had "consistently assessed the pertinent research and there is lacking reliable evidence that demonstrates a verified association between consuming paracetamol and autism."

Groups speaking for physicians and medical practitioners concur.

ACOG has declared acetaminophen - the main ingredient in acetaminophen - is among limited choices for women during pregnancy to manage discomfort and fever, which can present significant medical dangers if ignored.

"In more than two decades of research on the use of acetaminophen in pregnancy, no reliable research has successfully concluded that the use of paracetamol in any period of pregnancy leads to neurological conditions in children," the association said.

This legal action references latest statements from the previous government in claiming the drug is potentially dangerous.

Recently, the former president generated worry from health experts when he instructed expectant mothers to "fight like hell" not to use acetaminophen when ill.

The US Food and Drug Administration then released a statement that medical professionals should think about restricting the use of Tylenol, while also declaring that "a causal relationship" between the medication and autism spectrum disorder in minors has not been proven.

The Health Department head RFK Jr, who supervises the Food and Drug Administration, had promised in April to undertake "comprehensive study program" that would determine the source of autism spectrum disorder in a matter of months.

But specialists advised that discovering a sole reason of autism spectrum disorder - considered by experts to be the result of a intricate combination of genetic and surrounding conditions - would be difficult.

Autism spectrum disorder is a form of enduring cognitive variation and condition that affects how individuals encounter and relate to the environment, and is identified using physician assessments.

In his lawsuit, the attorney general - aligned with the former president who is running for the Senate - asserts Kenvue and Johnson & Johnson "intentionally overlooked and sought to suppress the research" around paracetamol and autism.

The lawsuit aims to force the firms "remove any commercial messaging" that claims Tylenol is safe for expectant mothers.

This legal action echoes the concerns of a collection of parents of young ones with autism spectrum disorder and ADHD who sued the producers of Tylenol in 2022.

The court threw out the lawsuit, saying investigations from the family's specialists was not conclusive.